| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0042-6822(88)90692-7 |
| P698 | PubMed publication ID | 3291388 |
| P2093 | author name string | Knight JC | |
| Novembre FJ | |||
| Baer GM | |||
| Esposito JJ | |||
| Shaddock JH | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rabies | Q39222 |
| rabies virus | Q698976 | ||
| P304 | page(s) | 313-316 | |
| P577 | publication date | 1988-07-01 | |
| P1433 | published in | Virology | Q7934867 |
| P1476 | title | Successful oral rabies vaccination of raccoons with raccoon poxvirus recombinants expressing rabies virus glycoprotein | |
| P478 | volume | 165 |
| Q36559952 | A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein |
| Q44927745 | A recombinant vaccinia-rabies virus in the immunocompromised host: oral innocuity, progressive parenteral infection, and therapeutics |
| Q35294027 | Biological control of wild animal infections |
| Q44848508 | Characterization of rabies glycoprotein expressed in yeast |
| Q35845061 | Cross-protection of mice against a global spectrum of rabies virus variants |
| Q37249251 | Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety |
| Q69389636 | How do other poxviruses fit in as potential vectored vaccine substrates for animal immunizations? |
| Q40533280 | Infectivity of attenuated poxvirus vaccine vectors and immunogenicity of a raccoonpox vectored rabies vaccine in the Brazilian Free-tailed bat (Tadarida brasiliensis). |
| Q41053445 | Mucosal administration of raccoonpox virus expressing highly pathogenic avian H5N1 influenza neuraminidase is highly protective against H5N1 and seasonal influenza virus challenge |
| Q41006477 | Non-replicating expression vectors: applications in vaccine development and gene therapy |
| Q59809171 | Oncolytic properties of non-vaccinia poxviruses |
| Q36523757 | PCR strategy for identification and differentiation of small pox and other orthopoxviruses. |
| Q33931640 | Potent oncolytic activity of raccoonpox virus in the absence of natural pathogenicity |
| Q40886502 | Poxvirus vectors: cytoplasmic expression of transferred genes |
| Q33731344 | Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines |
| Q34431934 | Protection of Sheep against Rift Valley Fever Virus and Sheep Poxvirus with a Recombinant Capripoxvirus Vaccine |
| Q41924718 | Protection of bats (Eptesicus fuscus) against rabies following topical or oronasal exposure to a recombinant raccoon poxvirus vaccine |
| Q37521877 | Protection of black-tailed prairie dogs (Cynomys ludovicianus) against plague after voluntary consumption of baits containing recombinant raccoon poxvirus vaccine |
| Q42621297 | Protection of mice with vaccinia virus recombinants that express the rabies nucleoprotein |
| Q57152811 | Rabies Virus Antibodies from Oral Vaccination as a Correlate of Protection against Lethal Infection in Wildlife |
| Q36653651 | Rabies virus antinucleoprotein antibody protects against rabies virus challenge in vivo and inhibits rabies virus replication in vitro |
| Q40896734 | Rabies: a review |
| Q47326782 | Raccoon poxvirus as a mucosal vaccine vector for domestic cats |
| Q45760421 | Raccoon poxvirus live recombinant feline panleukopenia virus VP2 and rabies virus glycoprotein bivalent vaccine |
| Q41585052 | Raccoon poxvirus rabies virus glycoprotein recombinant vaccine in sheep |
| Q34106638 | Raccoon poxvirus recombinants expressing the rabies virus nucleoprotein protect mice against lethal rabies virus infection |
| Q34174062 | Recombinant raccoon pox vaccine protects mice against lethal plague |
| Q37126266 | Reflections on the early development of poxvirus vectors |
| Q36696504 | Sickness and recovery of dogs challenged with a street rabies virus after vaccination with a vaccinia virus recombinant expressing rabies virus N protein |
| Q45751770 | Swinepox virus as a vaccine vector for swine pathogens. |
| Q34357131 | Sylvatic plague vaccine: a new tool for conservation of threatened and endangered species? |
| Q36504012 | The development and use of a vaccinia-rabies recombinant oral vaccine for the control of wildlife rabies; a link between Jenner and Pasteur |
| Q26995905 | The evolution of poxvirus vaccines |
| Q34211635 | Vaccinia virus vectors: new strategies for producing recombinant vaccines |
| Q37755852 | Vaccinia virus: a tool for research and vaccine development |
| Q63884731 | Virally-vectored vaccine candidates against white-nose syndrome induce anti-fungal immune response in little brown bats (Myotis lucifugus) |
Search more.